Quantinno Capital Management LP Buys Shares of 8,875 Nutex Health Inc. $NUTX

Key Points

• Quantinno Capital Management bought 8,875 Nutex Health shares worth approximately $843,000, giving it a 0.13% stake. Institutional investors and hedge funds collectively own 5.32% of NUTX.
• Analyst sentiment is generally positive: Nutex Health has a consensus rating of “Moderate Buy” and an average price target of $268.33, with Lake Street raising its target to $310.
• Nutex Health reported quarterly EPS of $9.38, beating estimates of $4.95, while revenue came in at $210.75 million versus expectations of $215.03 million. Shares opened at $188.41, near the company’s 52-week high of $204.

Quantinno Capital Management LP purchased a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 8,875 shares of the company's stock, valued at approximately $843,000. Quantinno Capital Management LP owned approximately 0.13% of Nutex Health at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in NUTX. Islay Capital Management LLC acquired a new stake in Nutex Health during the 4th quarter worth approximately $34,000. BNP Paribas Financial Markets raised its stake in shares of Nutex Health by 966.7% during the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock valued at $40,000 after acquiring an additional 290 shares during the last quarter. Royal Bank of Canada lifted its holdings in shares of Nutex Health by 752.4% during the fourth quarter. Royal Bank of Canada now owns 358 shares of the company's stock worth $59,000 after purchasing an additional 316 shares during the period. Bank of America Corp DE increased its holdings in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after purchasing an additional 2,043 shares during the period. Finally, Vestcor Inc acquired a new stake in shares of Nutex Health in the third quarter valued at about $111,000. Institutional investors and hedge funds own 5.32% of the company's stock.

Analyst Upgrades and Downgrades

NUTX has been the topic of several analyst reports. Lake Street Capital reiterated a "buy" rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Monday, July 20th. Zacks Research upgraded shares of Nutex Health to a "hold" rating in a research report on Monday, June 29th. B. Riley Financial assumed coverage on shares of Nutex Health in a research note on Friday, June 26th. They issued a "buy" rating and a $290.00 price objective on the stock. Finally, Weiss Ratings upgraded shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, July 28th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Nutex Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $268.33.

Nutex Health Stock Performance

Shares of NUTX opened at $188.41 on Tuesday. The stock has a 50 day moving average price of $163.45 and a two-hundred day moving average price of $130.23. Nutex Health Inc. has a 52 week low of $77.21 and a 52 week high of $204.00. The firm has a market capitalization of $1.29 billion, a P/E ratio of 7.40 and a beta of 0.24. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The business had revenue of $210.75 million for the quarter, compared to analysts' expectations of $215.03 million. Equities analysts forecast that Nutex Health Inc. will post 30.11 earnings per share for the current fiscal year.

Nutex Health Profile

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source